CMDA | Aducanumab
Dr. Lea Watson covers two drugs, Nuplazid and the new one approved by the FDA, Aducanumab. Followed by Dr. Sing Palat, CMD and new President of CMDA who discusses the use of oxygen with nocturnal hypoxemia in COPD.
Recording Date: 5/6/2021
It is Free
Copyright © 2006-2022 Podbean.com